Skip to Primary Navigation

Skip to main content

QOL Medical and CEO fined $47m for kickback scheme

The company overstated diagnostic claims to boost sales of its flagship product Sucraid.

Article label: Quick Read
Premium article

Alexander Barzacanos

Doctor writing on clipboard
Photo: RunPhoto/Getty Images
Click to share on Facebook (Opens in new window/tab) Click to share on X (Opens in new window/tab) Click to share on LinkedIn (Opens in new window/tab) Click to share on WhatsApp (Opens in new window/tab)

Pharmaceutical company QOL Medical, and its CEO Frederik E Cooper, have agreed to pay $47m to the Department of Justice over charges that they paid illegal remuneration and therefore submitted false claims to Medicare, TRICARE, VA, and Medicaid, in violation of the False Claims Act (FCA) and Anti-Kickback Statute (AKS).

, , , , ,

Get full access, free for a month

This is a Premium article. Start your 28-day free trial to continue reading and access all content on GRIP – no payment details required.

Start free trial
Sign in

What’s included:

  • Every new article, plus our 6,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience